Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients. [electronic resource]
- The Annals of pharmacotherapy 10 2018
- 1031-1041 p. digital
Publication Type: Journal Article; Review
1542-6270
10.1177/1060028018768808 doi
Administration, Oral Aged Aged, 80 and over Bone Density Conservation Agents--economics Cost-Benefit Analysis Denosumab--economics Diphosphonates--administration & dosage Fractures, Bone--epidemiology Health Care Costs Humans Middle Aged Osteoporosis--drug therapy Patient Preference--statistics & numerical data Treatment Outcome Assessment of Medication Adherence